Application of Cultured Autologous Keratinocytes for Burn Wound Healing
KC
2 other identifiers
interventional
40
1 country
1
Brief Summary
In this study the treatment of full thickness burn wounds with cultured autologous keratinocytes in combination with meshed split skin autograft versus meshed split skin graft alone will be compared. It is expected that the application of cultured autologous keratinocytes in combination with a meshed split skin autograft will improve wound healing and scar formation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jun 2008
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 28, 2009
CompletedFirst Posted
Study publicly available on registry
January 29, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFebruary 17, 2020
June 1, 2014
4.3 years
January 28, 2009
February 13, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary end point is the percentage of wound closure.
7 days
Secondary Outcomes (1)
Secondary objective is scar quality (i.e. subjective scar assessment, scar elasticity, colour and pigmentation of the scar and smoothness of the scar surface).
3 and 12 months
Study Arms (2)
1
EXPERIMENTALwound 1: the placement of keratinocytes onto a collagen/elastin support after the application of the meshed split skin autograft.
2
OTHERcontrol wound site; application of mesh graft alone
Interventions
The experimental wound site will be covered with cultured keratinocytes on a collagen/elastin carrier after the application of a meshed split skin autograft. The control wound site will be covered with a meshed split skin autograft alone.
Eligibility Criteria
You may qualify if:
- Competent and temporarily incompetent patients 18 years of age or older with acute burn wounds that require widely meshed skin grafting, which do not need immediate excision
- Minimal study wound area 100 cm2
- Maximal study wound area 300 cm2
- Maximal TBSA 30% full thickness wounds
- Informed consent
You may not qualify if:
- Immunocompromised patients
- Infected wounds
- Use of high doses of (.20mg/pd) corticosteroids and/or cytostatica
- Known penicillin allergy
- Conditions where the patient is non compliant as judged by a medical specialist
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Red Cross Hospital
Beverwijk, North Holland, 1942 LE, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
E Middelkoop, Prof
Association of Dutch Burn Centers
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2009
First Posted
January 29, 2009
Study Start
June 1, 2008
Primary Completion
September 1, 2012
Study Completion
September 1, 2013
Last Updated
February 17, 2020
Record last verified: 2014-06